Antidiabetics prescribed at the expense of the statutory health insurance (millions of defined daily doses (DDD)). Classification: years, Germany, antidiabetic

Type of antidiabetic	Year (descending)
	1994	2000	2005	2010	2015	2020	2021
Total antidiabetics	1,006	1,161	1,628	2,051	2,112	2,422	2,496
Total insulins	264	458	704	810	835	839	788
Human insulins	244	458	471	471	327	184	158
Insulin analogues	.	.	233	339	509	655	629
Animal insulins	20	.	.	.	.	-	-
Oral antidiabetics total	742	703	925	1,240	1,276	1,583	1,709
Sulfonylureas	618	455	430	436	243	131	115
Metformin	61	183	379	578	587	680	699
Glinides	.	8	37	33	27	3	3
Incretinmimetics	.	.	.	126	374	539	593
Other oral antidiabetics	63	57	80	67	45	231	300

Change table

Show value selection

  (On the page "Value selection" you can choose for every dimension any dimension value for your selection.)

---

Source(s)/Contact

• German Drug Index, AOK Research Institute (WIdO) (more information on 
  Popup
  , more information on 
  Popup
  )

Definition(s)

• Popup

Comment(s)

• Various pharmaceuticals are not reported continuously over all of the reporting years.
• Deviations in the sums result from rounding off the figures.

Refresh period of data

• The table was extended by the year 2021 on 04 May 2023.
  Information for a new reporting period will be added as soon as it is available.

Links

• Information concerning oral antidiabetics .
• Information concerning insulin preparations .

Signs and symbols

• .   = Data unknown or confidential

The Federal Health Monitoring System 19. Apr 2024